2016 has been a big year for technology transfer offices in Australia. As we all know, commercialising research is a tough gig and some deals are many years in the making. The beginning of a new tradition, KCA has compiled a highlights list from offices around the country to celebrate the achievements of the membership across the year just gone. You may have heard of some of these achievements throughout the year, but its always nice to look at these things in summary, and consider at what has been accomplished as a group. Below are some top 3 highlights from offices within the KCA community who were able to participate in the exercise this year.
- Successful technology transfer and scale up of the ANSTO Minerals Sileach™ process with Lithium Australia. More info here.
- ANSTO in partnership with Minomic have successfully developed the MILGa drug for SPECT diagnosis of certain cancers. Minomic is mid-way through a Phase 1 clinical trial. Story here.
- ANSTO Health obtained a license from the TGA for production of Lutetium 177, an emerging therapeutic isotope for a range of cancers. Story here.
- Launch and expansion of the ON Accelerator to all Public Sector Research Organisations and Universities funded through NISA. More info here.
- The announcement of the $200 million CSIRO Innovation Fund to be operational in 2017 and also available to all Public Sector Research Organisations and Universities. More info here.
- 5 spin outs/equity deals in calendar 2016 and $60m in IP (royalty and licensing) revenue in 2015/16 FY (Chryos, Cardihab, MetaBloQ, Smart Battery)
- West Tech Fest, which incorporates the OzAPP Awards judging, a Startup Village, pitching opportunities, an angel investor dinner, student tech fest, technology startup events and an industry conference.
- Curtin spinout ePAT technologies listed on the ASX completing a $4.7 million capital raise.
- Curtin completed a deal with Australian mining services company, Gekko Systems to commercialise a breakthrough gold processing monitoring technology. Story here.
- HPRNet – DST Group in partnership with the Australian Army has established new model for establishing research networks(Rnet) of Australian Universities to undertake research in areas of interest to Defence . The first such RNet is a joint initiative of DST Group and the Australian Army which has brought together 7 Australian universities to work in the area of the advancement of human performance . Next year will see this model being used in other technology areas.
- External Engagement Manager program – 12 month professional development and immersive program whereby DST researchers are appointed as their respective Research Division’s External engagement manager. As a result of the program researchers have not only increased their business acumen and commercial skills but 60% of the researchers have gained promotions back inside their research areas.
- CERA business model – Devised the business model whereby the Defence Science Institute (DSI) released a pilot Competitive Evaluation Research Agreement (CERA) program, which sought research proposals from Australian universities relating to projects of Defence strategic importance. In a highly competitive field DSI made award grants of up to $50k each to seed collaborations. The strongest applicants were able to collaborate and engage with Australian industry and International partners. Given the success of the pilot program DST Group has requested the program be continued in the coming financial year.
- Griffith University and agricultural product company Agnova Technologies collaborated to produce Fruition, the nation’s first non-toxic commercial response to fruit flies. Story here.
- Student enterprise (student entrepreneurial education is a key growth area for Griffith. Story here.
- Olymvax invests in Griffith vaccine for Strep A. Story here.
- La Trobe establishes the new Office of the Pro Vice-Chancellor (Industry Engagement). Story here.
- Unlocking regional Victoria’s big ideas – LaunchVic funded Regional Accelerator Program. Story here.
- Optus and La Trobe tech-collaboration to deliver an integrated, digitally connected campus; a state-of-the-art Sports Precinct of the Future; and creation of a market leading Cyber Security tertiary degree. Story here.
- Macquarie University has had one or more team(s) in every CSIRO ON program that were eligible to Universities; Modular Photonics in ACCELERATE 2, LuciGem, FAIMS and Diamond Lasers in PRIME and LuciGem in ACCELERATE 3.
- 2016 has seen over a double increase in Innovation Disclosures since 2015 (57 as of 08 Dec 2016)
- We arranged a educational and fun team bonding session with the Research Office, Office of Commercialisation and Innovation and Corporate Engagement by holding a 1 day negotiation training workshop.
- BioCurate is an $80M collaboration between Monash and the University of Melbourne established to transform our ability to translate our world class biomedical research into new therapeutic products. Story here.
- Monash University spinout Amaero Engineering entered into a major production deal with French based multinational company Safran to produce 3D printed parts for Safran. Story here and here.
- Monash and Hudson Institute of Medical Research entered into a major commercialisation and co-development deal to develop next generation immunology therapeutics. Story here.
- A €15 million (A$22 million) Series A investment (one of the largest biotech Series A investments for intellectual property originating from an Australian university) in Inflazome Ltd, a company founded on research from UQ and Trinity College Dublin, developing treatments for inflammatory diseases. Story here.
- UniQuest’s Queensland Emory Drug Discovery Initiative (QEDDI) became a fully-equipped and operational drug discovery and development capability, with facilities and staff based at UQ’s Institute for Molecular Bioscience.
- UQ spinout company Protagonist Therapeutics Inc. listed on the NASDAQ stock market, raising US$90 million (A$118 million) in its initial public offering, (story here), while ResApp is developing a smartphone medical application for the diagnosis and management of respiratory disease, and has raised more than A$16 million since listing on the Australian Stock Exchange in 2015 (story here).
- UniSA’s Venture Catalyst program voted Australia’s Best Entrepreneurial Support Initiative in the KCA Awards. Story here.
- UniSA signed a MoU with one of China’s leading drug development and pharmaceuticals manufacturers, to support the development of new drugs, and treatments in stem cell biology and drug reformulation technology. Story here.
- UniSA launched a new strategic plan for research and innovation to fast-track the development of high potential innovations through UniSA Ventures. Story here.
- China Cable deal worth $20m that was KCA deal of the year. Story here.
- Quantum Computing deal which saw $25m of Commonwealth funding through NISA, and $10m each from CBA and Telstra to develop a prototype circuit. Story here.
- Torch Innovation Precinct announcement that the first Torch Science Park outside China would be set-up at UNSW. More info here.
- A new drug for the treatment of Duchenne Muscular Dystrophy (DMD) originally developed at The University of Western Australia has been approved by the US Food and Drug Administration. Story here.
- The first ever Western Australian Innovation Strategy was launched by the Minister for Innovation, the Hon Bill Marmion, on 2 November 2016. Story here.
- An increase in support activity for entrepreneurship and innovation in Perth, i.e. CERI is an independent, not-for-profit organisation that has been set up to work closely with local researchers to assist them in developing entrepreneurial skills and to then take them through the Innovation Process, with the goal of assisting them to establish a startup company.
- Researchers at Victoria University have joined forces with Phillip Island Nature Parks to develop a ‘wand’ that harvests oil absorbing magnetic particles in order to save the lives of penguins and other birds contaminated after an oil spill event. Story here.
- A patent and trademark technology licence to a company in Japan to commercialise innovative insole technology develop at ISEAL (Institute of Sport, Exercise & Active Living) research institute as well as leveraging our reputation and famous associated brand. The insoles have major biomechanical advantages over the existing products in the market. Deals are currently being negotiated with major insole and shoe manufacturers and distributors in Asia and beyond to bring this inventive product to market.
- A patent technology licence to an Australian company to exploit membrane distillation technology. The technology has energy and practical advantages that the company has secured investment and is building a pilot plant to scale up the technology. The company already has end market customers interested in using the technology in a broad range of industrial applications.